Eye Examination Equipment Market

Global Eye Examination Equipment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals Clinics, and Others), By Application, By Product, By Regional Outlook and Forecast, 2023 - 2030

Report Id: KBV-17476 Publication Date: September-2023 Number of Pages: 327
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Global Eye Examination Equipment Market size is expected to reach $9.4 billion by 2030, rising at a market growth of 6.4% CAGR during the forecast period.

The optical coherent tomography (OCT) scanners work on the principle of low-coherence interferometry. Consequently, the optical coherent tomography (OCT) scanners segment will register more than 1/5th share of the market by 2030 They emit a beam of near-infrared light split into two paths. One path is directed into the examined tissue, while the other is directed into a reference mirror. The light reflected or scattered back from the tissue is combined with the reference light, and the interference pattern is analyzed to create an image. OCT scanners have revolutionized medical imaging by providing non-invasive, high-resolution imaging capabilities across various medical specialties.

Eye Examination Equipment Market Size - Global Opportunities and Trends Analysis Report 2019-2030

The major strategies followed by the market participants are Partnerships as the key developmental strategy in order to keep pace with the changing demands of end users. In February, 2023, NIDEK came into partnership with HOYA Vision Care with an aim to deliver eye care professionals a chance to access a comprehensive portfolio of optical instruments and products. In August, 2021, Topcon teamed up with RetInSight GmbH. This partnership would lead to enhanced clinical decision-making and efficient disease management.

KBV Cardinal Matrix - Market Competition Analysis

Based on the Analysis presented in the KBV Cardinal matrix; Johnson & Johnson (Johnson & Johnson Vision Care, Inc.) is the major forerunner in the Market. In September, 2021, Johnson & Johnson partnered with Black EyeCare Perspective to support the future of optometry and work together to create quality, equitable experiences along with healthier outcomes across communities. Companies such as Topcon Corporation, Carl Zeiss Meditec AG (Carl Zeiss AG) and Nidek Co., Ltd. are some of the key innovators in the Market.

Eye Examination Equipment Market - Competitive Landscape and Trends by Forecast 2030

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted various sectors, including the healthcare industry and the market for eye examination equipment. During the initial stages of the pandemic, many manufacturing facilities and supply chains were disrupted due to lockdowns, labor shortages, and restrictions on movement. This caused delays in the manufacturing and distribution of eye examination equipment, resulting in potential shortages in certain regions. As a result, the demand for eye examination equipment temporarily declined. The pandemic raised understanding of the significance of eye health, especially among individuals spending more time on digital devices for work and leisure. This further led to a long-term increase in demand for eye examinations and related equipment. Although there may have been short-term difficulties, the market's future outlook is still favorable because eye health is vital to overall healthcare.

Market Growth Factors

Increasing Proportion of an Ageing Population

The WHO reports that people are living longer overall. Most people today plan to live until their sixties and beyond. By 2030, one in six people will be 60 or older. 1.4 billion people will be above 60 by now, up from 1 billion in 2020. Two-thirds of the world's population over 60 will live in low- and middle-income nations by 2050. The aging population's increased susceptibility to age-related eye conditions and the recognition of the importance of regular eye exams drive the demand. This demographic shift positively impacts the market by fostering growth, innovation, and improved eye care services for older adults.

Growing Incidence of Eye Disorders

Modern lifestyles, characterized by increased screen time, exposure to digital devices, and limited outdoor activities, have contributed to a higher incidence of conditions like digital eye strain, myopia (near-sightedness), and dry eye syndrome. The rising prevalence of diabetes, especially type 2 diabetes, is closely linked to an increased incidence of diabetic retinopathy. The increasing prevalence of eye disorders has necessitated early detection and treatment, driving demand. In addition, increasing eye care awareness and the accessibility of technologically advanced eye examination equipment are expected to drive market growth over the forecast period.

Market Restraining Factors

Lack of Eye Care Awareness in Low-Income Countries

Low awareness and limited access to eye care in low-income economies pose a significant obstacle for the market. Access to eye care services and equipment is extremely limited in many developing nations. This lack of access can result in a lack of awareness regarding the significance of regular eye examinations and the dangers of vision loss. In addition, efforts must be made to increase the accessibility of eye examination equipment in low-income countries so that individuals can access the necessary tools for diagnosing and treating vision-related issues. Due to limited eye care awareness in economies with low income, the market will be hampered.

End Use Outlook

Based on end-use, the market is fragmented into hospitals, clinics, and others. In 2022, the hospitals segment registered the highest revenue share in the market. It is crucial for diagnosing and monitoring various eye conditions and diseases in hospitals and other healthcare settings. Ophthalmologists, optometrists, and other eye care professionals use these tools and devices to assess patients' visual health and provide appropriate treatment. Hospitals are vital for providing comprehensive eye care, early diagnosis of eye diseases, and proper treatment and management of visual and ocular conditions.

Application Outlook

By application, the market is classified into glaucoma, cataract, refractive errors, age related macular degeneration, and others. The cataract segment recorded a remarkable revenue share in the market in 2022. While cataract treatment primarily involves surgical intervention, eye examination equipment plays a significant role in diagnosing, evaluating, and preparing for cataract surgery. These devices measure a patient's refractive error and corneal curvature. These measurements are crucial for calculating the intraocular lens (IOL) power needed to correct vision during cataract surgery. Advances in these technologies continue to enhance the safety and effectiveness of cataract diagnosis and treatment.

Eye Examination Equipment Market Share and Industry Analysis Report 2022

Product Outlook

On the basis of product, the market is segmented into optical coherent tomography (OCT) scanners, ophthalmic ultrasound imaging systems, corneal topography systems, slit lamps, tonometer, ophthalmoscopes, perimeters/visual field analyzers, fundus cameras, autorefractors & keratometers (phoropters), and others. The slit lamps segment covered a considerable revenue share in the market in 2022. A slit lamp is a crucial piece of eye examination equipment used by ophthalmologists and optometrists to examine the various structures of the eye, including the anterior segment (front part of the eye). It consists of a binocular microscope with an adjustable light source that produces a thin, intense light beam. They play a pivotal role in diagnosing and monitoring eye conditions, guiding treatment decisions, and assessing the fit and comfort of contact lenses. The integration of advanced imaging technologies further enhances their diagnostic capabilities.

Eye Examination Equipment Market Report Coverage
Report Attribute Details
Market size value in 2022 USD 5.8 Billion
Market size forecast in 2030 USD 9.4 Billion
Base Year 2022
Historical Period 2019 to 2021
Forecast Period 2023 to 2030
Revenue Growth Rate CAGR of 6.4% from 2023 to 2030
Number of Pages 327
Number of Table 444
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered Product, Application, End-use, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers
  • Increasing Proportion of an Ageing Population
  • Growing Incidence of Eye Disorders
Restraints
  • Lack of Eye Care Awareness in Low-Income Countries

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region witnessed the largest revenue share in the market. This will be due to the expanding number of individuals with vision impairment, which will offer an enormous challenge to eye care service providers, prompting them to acquire advanced diagnostic equipment. The market is driven by the rising number of moderate-to-severe visual impairments and myopia due to the growing elderly population. Increasing investments by governments and other private organizations to address the region's significant unmet healthcare requirements will likely stimulate the market's expansion.

Free Valuable Insights: Global Eye Examination Equipment Market size to reach USD 9.4 Billion by 2030

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Alcon, Inc., Ziemer Ophthalmic Systems AG, Nidek Co., Ltd., Topcon Corporation, Carl Zeiss Meditec AG (Carl Zeiss AG), Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), EssilorLuxottica SA (Essilor Instruments USA), Metall Zug AG (Metall Zug AG), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), and HEINE Optotechnik GmbH & Co. KG.

Strategies deployed in the Market

» Partnerships, Collaborations and Agreements:

  • Feb-2023: NIDEK came into partnership with HOYA Vision Care, a key player in optical technology innovation. The partnership delivers eye care professionals a chance to access a comprehensive portfolio of optical instruments and products. Further, this partnership enables NIDEK to furnish ECPs with flawless eyecare solutions, thereby enabling ECPs to deliver enhanced patient satisfaction.
  • Sep-2021: Johnson & Johnson partnered with Black EyeCare Perspective, a not-for-profit organization dedicated to redefining the color of the eyecare industry 1% at a time. This partnership would support the future of optometry and work together to create quality, equitable experiences along with healthier outcomes across communities.
  • Aug-2021: Topcon teamed up with RetInSight GmbH, a developer of retina AI solutions based in Vienna, Austria. This acquisition would lead to enhanced clinical decision-making and efficient disease management. This acquisition aimed at extending retinal fluid detection and monitoring to primary eye care providers, facilitating co-management of patients.
  • Apr-2021: Johnson & Johnson teamed up with Menicon, a contact lens manufacturer. Under this acquisition, Menicon would develop & manufacture contact lenses to help manage the progression of myopia in children. This collaboration would bring a portfolio of differentiated products to help manage the progression of myopia in children, as Johnson & Johnson works toward the vision of helping the world see better, connect better, and live better.

» Product Launches and Product Expansions:

  • Sep-2022: Johnson & Johnson Vision introduced Acuvue Oasys Max 1-day contact lenses. Acuave Oasys Max 1-day contact lenses would help reduce discomfort by providing visual clarity with new technologies to filter blue-violet light, that comes from many sources, including digital screens, and travels in short wavelengths and scatters more that may lead to eye discomfort and quality of vision.

» Acquisitions and Mergers:

  • Apr-2022: Carl Zeiss Meditec acquired Kogent Surgical and Katalyst Surgical, two manufacturers of surgical instruments. This acquisition would strengthen the company's positioning as a solution provider. This acquisition would further scale the businesses & contribute to the surgical solution offering and add recurring revenue.
  • Jan-2022: Alcon completed the acquisition of Ivantis, developer of the novel Hydrus Microstent. Through this acquisition, Alcon looks forward to release Hydrus Microstent on a broader, worldwide scale in the upcoming years to help even more patients see brilliantly.
  • Jul-2021: Topcon Corporation took over VISIA Imaging S.r.l, an ophthalmic device manufacturer. This acquisition focused on Topcon's development & manufacturing capabilities of anterior segment devices, and software, which complements the company's portfolio of posterior segment imaging devices that include fundus cameras as well as optical coherence tomography.
  • Mar-2021: Zeiss Vision Care took over U.S. Vision’s optical laboratory. Under this acquisition, Zeiss added manpower & production facility of U.S. Vision's optical laboratory to its business which would complement its growth strategy.

» Approvals:

  • Apr-2022: ZEISS Medical Technology got US FDA approval for QUATERA 700, a revolution in phaco technology. Together with the ZEISS Medical Ecosystem and surgical planning software, we believe this fully connected and integrated approach will help set new standards for patient care and clinical management.
  • May-2021: Johnson & Johnson got FDA approval ACUVUE Abiliti, overnight therapeutic lenses for myopia Management. This approval would support the company's commitment to help change the trajectory of eye health. This approval would provide eye care professionals and patients with more options to deal with myopia.
  • Apr-2021: Bausch + Lomb got USFDA approval for ClearVisc dispersive ophthalmic viscosurgical device (OVD). ClearVisc offers significant advantages that could help surgeons deliver the best possible outcomes for their patients.

Scope of the Study

Market Segments Covered in the Report:

By End Use

  • Hospitals
  • Clinics
  • Others

By Application

  • Glucoma
  • Cataract
  • Refractive Errors
  • Age Related Macular Degeneration
  • Others

By Product

  • Optical Coherent Tomography (OCT) Scanners
  • Ophthalmic Ultrasound Imaging Systems
  • Corneal Topography Systems
  • Slit Lamps
  • Tonometer
  • Ophthalmoscopes
  • Perimeters/Visual Field Analysers
  • Autorefractors & Keratometers (Phoropters)
  • Fundus Cameras
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Alcon, Inc.
  • Ziemer Ophthalmic Systems AG
  • Nidek Co., Ltd.
  • Topcon Corporation
  • Carl Zeiss Meditec AG (Carl Zeiss AG)
  • Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
  • EssilorLuxottica SA (Essilor Instruments USA)
  • Metall Zug AG (Metall Zug AG)
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • HEINE Optotechnik GmbH & Co. KG
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

Frequently Asked Questions About This Report

This Market size is expected to reach $9.4 billion by 2030.

Increasing Proportion of an Ageing Population are driving the Market in coming years, however, Lack of Eye Care Awareness in Low-Income Countries restraints the growth of the Market.

Alcon, Inc., Ziemer Ophthalmic Systems AG, Nidek Co., Ltd., Topcon Corporation, Carl Zeiss Meditec AG (Carl Zeiss AG), Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), EssilorLuxottica SA (Essilor Instruments USA), Metall Zug AG (Metall Zug AG), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), and HEINE Optotechnik GmbH & Co. KG.

The expected CAGR of this Market is 6.4% from 2023 to 2030.

The Glucoma segment is leading the Market by Application in 2022; thereby, achieving a market value of $3.3 billion by 2030.

The North America region dominated the Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $3.3 billion by 2030.

HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo